Deficiency in MMR (dMMR) disrupts genomic stability, resulting in a high tumor mutational burden (TMB), accumulation of immunogenic neoantigens, and infiltration of cytotoxic T cells into the tumor microenvironment [5]. The gene discussed is MRC1; the disease is neoplasm.